⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31115 | 0.72 | — | — | |
| SCHEMBL17616038 | 0.72 | — | — | |
| Water SCHEMBL11805223 | 0.67 | — | — | |
| SCHEMBL8948 | 0.67 | — | — | |
| SCHEMBL7893123 | 0.67 | — | — | |
| SCHEMBL1275690 | 0.67 | — | — | |
| SCHEMBL13591500 | 0.67 | — | — | |
| SCHEMBL1425834 | 0.67 | — | — | |
| SCHEMBL5861030 | 0.67 | FFAR3 (0.40) | — | |
| SCHEMBL23572290 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1022 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240238265-A1 | ADAMANTANE AMIDES AND THIOAMIDES FOR THE TREATMENT OF EBOLAVIRUS INFECTION | ARISAN THERAPEUTICS INC. (US) | 2024-07-18 | — | — | US | disclosed |
| US-20230339902-A1 | TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4 | C4 THERAPEUTICS, INC. (US) | 2023-10-26 | — | — | US | disclosed |
| US-20230287001-A1 | Organic Semiconducting Compounds | RAYNERGY TEK INC (TW) | 2023-09-14 | — | — | US | disclosed |
| EP-3835290-B1 | OXADIAZOLINE COMPOUND OR SALT THEREOF, AGRICULTURAL OR HORTICULTURAL BACTERICIDE CONTAINING SAID COMPOUND, AND USE METHOD THEREFOR | NIHON NOHYAKU CO LTD (JP) | 2023-09-06 | — | — | EP | disclosed |
| US-20230202977-A1 | CYCLIC LIPIDS AND METHODS OF USE THEREOF | RENAGADE THERAPEUTICS MANAGEMENT INC. | 2023-06-29 | — | — | US | disclosed |
| US-20230183254-A1 | METHOD OF MAKING SUBSTITUTED IMIDAZO[4,5-c]PYRAZOLES | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2023-06-15 | — | — | US | disclosed |
| EP-4194438-A1 | ACETAL-BASED COMPOUND, ACETAL-BASED PREPOLYMER, ACETAL-BASED POLYMER, AND PHOTORESIST COMPOSITION COMPRISING THE SAME | Samsung Electronics Co., Ltd. (KR) | 2023-06-14 | — | — | EP | disclosed |
| US-11674162-B2 | Selective advantage in fermentation | GINKGO BIOWORKS, INC. (US) | 2023-06-13 | — | — | US | disclosed |
| US-20230121730-A1 | OXADIAZOLINE COMPOUNDS OR SALTS THEREOF, AGROHORTICULTURAL FUNGICIDES CONTAINING THE COMPOUNDS, AND METHODS OF USING THE SAME | NIHON NOHYAKU CO., LTD. (JP) | 2023-04-20 | — | — | US | disclosed |
| US-20230032098-A1 | ENCAPSULATED PRO-PERFUME COMPOUNDS | FIRMENICH SA (CH) | 2023-02-02 | — | — | US | disclosed |
| EP-1745784-A1 | Oxazolidinone derivatives and use thereof as antibiotics | FERRER INTERNACIONAL, S.A. (ES) | 2007-01-24 | — | — | EP | disclosed |
| US-7166588-B2 | Derivatives and analogs of galanthamine | SANOCHEMIA PHARMAZEUTIKA AKTIENGESELLSCHAFT (AT) | 2007-01-23 | — | — | US | disclosed |
| US-7166588-B2 | Derivatives and analogs of galanthamine | SANOCHEMIA PHARMAZEUTIKA AKTIENGESELLSCHAFT (AT) | 2007-01-23 | — | — | US | disclosed |
| US-20070004872-A1 | suitable for encapsulating solid state devices includes an epoxy resin( examples bisphenol A or F epoxy resin, phenol or cresol novolak resins etc.) a hardener, a poly(arylene ether) resin and sililca filler; curable; exhibits improved increased copper substrte adhesion and reduced shrinkage | CITIBANK, N.A., AS COLLATERAL AGENT | 2007-01-04 | — | — | US | disclosed |
| US-20070004871-A1 | Curable composition and method | CITIBANK, N.A., AS COLLATERAL AGENT | 2007-01-04 | — | — | US | disclosed |
| US-20070004819-A1 | A curable epoxy resin , two latent cationic curing catalyst, a free radical-producng cocatalyst and inorganic filler of about 70-95 weight % based on the total weight; catalyst allows the use of increased filler loadingsto reduce moisture absorption and thermal expansion; encapsulating solid state device | CITIBANK, N.A., AS COLLATERAL AGENT | 2007-01-04 | — | — | US | disclosed |
| WO-2007000432-A1 | OXAZOLIDINONE DERIVATIVES AND USE THEREOF AS ANTIBIOTICS | FERRER INTERNACIONAL, S. A. (ES) | 2007-01-04 | — | — | WO | disclosed |
| US-20070004904-A1 | G-CSF CONJUGATES | MAXYGEN HOLDINGS, LTD. | 2007-01-04 | — | — | US | disclosed |
| WO-2005087235-A1 | PYRROLIDINE COMPOUNDS | NATIONAL HEALTH RESEARCH INSTITUTES (CN) | 2005-09-22 | — | — | WO | disclosed |
| WO-2003034989-A2 | α-HYDROXYARYLBUTANAMINE INHIBITORS OF ASPARTYL PROTEASE | ENANTA PHARMACEUTICALS, INC. (US) | 2003-05-01 | — | — | WO | disclosed |